A carregar...
Publicação
Efavirenz concentrations in HIV-infected patients with and without viral hepatitis
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 443.02 KB | Adobe PDF |
Orientador(es)
Resumo(s)
AIMS: Data on efavirenz in HIV/viral hepatitis co-infected patients is non-consensual, probably due to liver function heterogeneity in the patients included.
METHODS: A case control study was performed on 27 HIV-infected patients, with controlled and homogenous markers of hepatic function, either mono-infected or co-infected with HBV/HCV, to ascertain the influence of viral hepatitis on efavirenz concentrations over a 2-year follow-up period.
RESULTS: No differences were found in efavirenz concentrations between groups both during and at the end of the follow-up period: control (2.43 +/- 1.91 mg l(-1)) vs. co-infected individuals (2.37 +/- 0.37 mg l(-1)).
CONCLUSION: It was concluded that HBV/HCV infections in themselves do not predispose to an overexposure to efavirenz.
Descrição
Palavras-chave
Infecção por HIV Hepatite B Hepatite C HIV infections Hepatitis B Hepatitis C Efavirenz
Contexto Educativo
Citação
Br J Clin Pharmacol. 2008 Oct;66(4):551-5